C34

• CAT Number: I011179
• CAS Number: 40592-88-9
• Molecular Formula: C17H27NO9
• Molecular Weight: 389.4
• Purity: ≥95%
• Target: HSC
• Solubility: Soluble to 50 mM in water and to 100 mM in DMSO
• Storage: -20°C
• IUPAC Name: [(2R,3S,4R,5R,6S)-5-acetamido-3,4-diacetyloxy-6-propan-2-yloxyoxan-2-yl]methyl acetate
• InChI: InChI=1S/C17H27NO9/c1-8(2)24-17-14(18-9(3)19)16(26-12(6)22)15(25-11(5)21)13(27-17)7-23-10(4)20/h8,13-17H,7H2,1-6H3,(H,18,19)/t13-,14-,15-,16-,17+/m1/s1
• InChIKey: KMIQMFHPUJUDMC-HHARLNAUSA-N
• SMILES: CC(C)OC1C(C(C(C(O1)COC(=O)C)OC(=O)C)OC(=O)C)NC(=O)C

TLR4-IN-C34（Cat No.:I011179） is a novel inhibitor belonging to a new class of compounds that target toll-like receptor 4 (TLR4). By inhibiting TLR4, it has the potential to act as an anti-inflammatory drug. Toll-like receptor 4 plays a crucial role in initiating inflammatory responses, and inhibiting its activity can help reduce inflammation. TLR4-IN-C34 offers promise as a therapeutic agent for various inflammatory conditions, providing a new approach to alleviate inflammation-related symptoms and potentially modulate immune responses in diseases such as sepsis, autoimmune disorders, and chronic inflammatory conditions.